Heat thErapy And mobiLity in COVID-19 Survivors
Eligible age
50–90 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restore functional capacity, it may not be feasible or enticing to many people with PASC. This clinical trial seeks to establish the tolerability and efficacy of at home lower-body heat therapy for improving functional capacity along with metabolic and vascular health in late-middle aged and older adults with PASC, also known as "long COVID".
Sponsor: University of Nebraska
You may qualify if…
- ✓ Between the ages of 50 and 90 years
- ✓ Free from orthopedic limitations that would prohibit performing leg exercise
- ✓ BMI \< 40 kg/m2 and weigh \< 400lbs
- ✓ Previously contracted Covid-19 and have persistent symptoms such as a fatigue or decline in physical function, for at least 2 months following SARS-CoV-2 infection
You may not qualify if…
- ✕ Unable to give written informed consent
- ✕ Women who are pregnant, breastfeeding, or likely to become pregnant within the next 6 months
- ✕ Women who are taking hormone therapy
- ✕ Claustrophobia
- ✕ Orthopedic limitations that would prohibit them from walking
- ✕ Currently enrolled in an exercise-based or respiratory muscle rehabilitation program.
Where it's recruiting
Omaha
Source: ClinicalTrials.gov · NCT06928116 · last updated 2026-07-17